Medicine & Life Sciences
Anti-Infective Agents
76%
Bacteria
25%
Cefazolin
48%
Cefoxitin
49%
Ceftazidime
44%
Ceftriaxone
43%
Cephalosporin Resistance
59%
Communicable Diseases
32%
Data Analysis
27%
Escherichia coli
26%
Gram-Negative Bacteria
75%
Income
30%
Infections
35%
Klebsiella
89%
Penicillins
37%
Pharmaceutical Preparations
15%
Proteus
95%
Pseudomonas
83%
Sputum
36%
Staphylococcus
38%
Staphylococcus aureus
64%
Tanzania
90%
Tertiary Care Centers
65%
Tertiary Healthcare
73%
Therapeutics
6%
Vancomycin
39%
Wound Infection
38%
Wounds and Injuries
18%
Agriculture & Biology
animal injuries
40%
anti-infective agents
57%
antibiotic resistance
72%
bacteria
10%
blood
10%
cefazolin
27%
cefoxitin
24%
ceftazidime
24%
ceftriaxone
24%
cephalosporins
21%
drugs
12%
Escherichia coli
11%
etiological agents
88%
Gram-negative bacteria
36%
income
16%
infection
39%
infectious diseases
19%
Klebsiella
45%
methodology
5%
penicillins
19%
Proteus
46%
Pseudomonas
34%
stakeholders
20%
Staphylococcus
19%
Staphylococcus aureus
33%
Tanzania
80%
vancomycin
21%
Social Sciences
contagious disease
24%
diagnostic
21%
drug
16%
hospital care
100%
income
16%
stakeholder
17%
Tanzania
78%